Andrew Dickinson's Securities Transactions at Gilead Sciences, Inc.

The filing details the securities transactions of Andrew Dickinson, an officer at Gilead Sciences, Inc. It includes the sale of 2,500 shares of common stock on 10/15/2025, with an aggregate market value of $295,200. The filing also lists recent transactions over the past three months, including sales of 2,500 shares on 09/15/2025 for $283,925 and 2,500 shares on 08/15/2025 for $296,325. Additionally, the filing outlines the acquisition of restricted stock at various dates, with amounts ranging from 109 to 555 shares. The transactions are part of a plan adopted on 08/29/2024.